Treatment of patients with arterial hypertension and metabolic syndrome. The role of the combination drugs

被引：0
|
作者：
Shilov, A. M. [1 ]
Dulaeva, M. S. [1 ]
Osia, A. O. [1 ]
Lishuta, A. S. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Trubetskaya Ul 8-2, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2014年 / 10卷 / 01期
关键词：
arterial hypertension; combination therapy; fixed-dose drug combination; enalapril; lercanidipine;
D O I：
10.20996/1819-6446-2014-10-1-92-98
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Data about the current approach to the choice of dual antihypertensive combinations in various clinical situations for treatment of hypertension are presented. Advantages and indications for the combination of an ACE inhibitor with a dihydropyridine calcium channel blocker are reviewed. Data from prospective studies on the efficacy and safety of combination of third generation calcium channel blocker lercanidipine with ACE inhibitor enalapril are presented.
引用
收藏
页码：92 / 98
页数：7
相关论文
共 50 条
  • [31] Optimization of treatment of patients with arterial hypertension in combination with coronary heart disease.
    Sheiko, S. O.
    Kolb, N. O.
    MEDICAL PERSPECTIVES-MEDICNI PERSPEKTIVI, 2018, 23 (02): : 119 - 125
  • [32] Combination therapy in patients with pulmonary arterial hypertension
    Ewert, R.
    Opitz, C. F.
    Schaeper, C.
    Glaeser, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (40) : S187 - S190
  • [33] METABOLIC RISK FACTORS IN PATIENTS WITH ARTERIAL HYPERTENSION
    Badrakh, Burmaa
    Unurjargal, Tsolmon
    Sukhbaatar, Amarjargal
    Myagmardorj, Rinchyenkhand
    JOURNAL OF HYPERTENSION, 2018, 36 : E145 - E145
  • [34] Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
    Medvedev, I. N.
    Kumova, T. A.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2008, (05): : 53 - 55
  • [35] Carotid intima-media thickness in arterial hypertension patients with and without metabolic syndrome
    Sharipova, G. Kh.
    Balakhonova, T. V.
    Mychka, V. B.
    Chazova, I. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (02): : 102 - 108
  • [36] The role of combination therapy in the treatment of hypertension
    Moser, M
    Black, HR
    AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (06) : 73S - 78S
  • [37] Choice of zofenopril and hydrochlorothiazide combination in the treatment of arterial hypertension
    Dzhaiani, N. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2011, 7 (05) : 613 - 619
  • [38] Treatment of Arterial Hypertension in Obese Patients
    Wenzel, Ulrich O.
    Benndorf, Ralf
    Lange, Sascha
    SEMINARS IN NEPHROLOGY, 2013, 33 (01) : 66 - 74
  • [39] Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome
    Medvedev, I. N.
    Kumova, T. A.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2007, (04): : 52 - 56
  • [40] Severity of carbohydrate metabolism disturbances, arterial hypertension stage, and lipid profile in patients with metabolic syndrome
    Zhernakova, Yu., V
    Chazova, I. E.
    Olimpieva, S. P.
    Kilikovskyi, V. V.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2012, 11 (02): : 13 - 18
12345